HSC Section 6 Nov2016 Green Book

8. Yamaoka Y, ed. Helicobacter pylori: Molecular Genetics and Cellular Biology. Nor- wich, England: Caister Academic Press; 2008. 9. Oridate N, Takeda H, Yamamoto J, et al. Helicobacter pylori seropositivity pre- dicts outcomes of acid suppression therapy for laryngopharyngeal reflux symptoms. Laryngoscope . 2006;116(4):547-553. 10. Tezer MS, Kockar MC, Koc¸kar O, Celik A. Laryngopharyngeal reflux finding scores correlate with gastroesophageal reflux disease and Helicobacter pylori expression. Acta Otolaryngol . 2006;126(9):958-961. 11. Gulcan EM, Varol A, Kutlu T, et al. Helicobacter pylori stool antigen test. Indian J Pediatr . 2005;72(8):675-678. 12. Oderda G, Rapa A, Ronchi B, et al. Detection of Helicobacter pylori in stool speci- mens by non-invasive antigen enzyme immunoassay in children: multicentre Ital- ian study. BMJ . 2000;320(7231):347-348. 13. Scott LJ, Dunn CJ, Mallarkey G, Sharpe M. Esomeprazole: a review of its use in the management of acid-related disorders. Drugs . 2002;62(10):1503-1538. 14. Ni YH, Lin JT, Huang SF, Yang JC, Chang MH. Accurate diagnosis of Helicobac- ter pylori infection by stool antigen test and 6 other currently available tests in children. J Pediatr . 2000;136(6):823-827. 15. Barry DW, Vaezi MF. Laryngopharyngeal reflux: more questions than answers. Cleve Clin J Med . 2010;77(5):327-334. 16. Thomson ABR, Barkun AN, Armstrong D, et al. The prevalence of clinically sig- nificant endoscopic findings in primary care patients with uninvestigated dys- pepsia: the Canadian Adult Dyspepsia Empiric Treatment–Prompt Endoscopy (CADET-PE) study. Aliment Pharmacol Ther . 2003;17(12):1481-1491. 17. Issing WJ, Karkos PD, Perreas K, Folwaczny C, Reichel O. Dual-probe 24-hour

ambulatory pH monitoring for diagnosis of laryngopharyngeal reflux. J Laryn- gol Otol . 2004;118(11):845-848. 18. Ahmad I, Batch AJ. Acid reflux management: ENT perspective. J Laryngol Otol . 2004;118(1):25-30. 19. Pinar E, Oncel IS, Calli C, Atalay M. Detection of gastroesophageal reflux by scin- tigraphy in patients with laryngopharyngeal symptoms and findings [in Turkish]. Kulak Burun Bogaz Ihtis Derg . 2003;10(4):153-158. 20. Yorulmaz I, Ozlugedik S, Kucuk B. Gastroesophageal reflux disease: symptoms versus pH monitoring results. Otolaryngol Head Neck Surg . 2003;129(5):582- 586. 21. Haruma K, Hamada H, Mihara M, et al. Negative association between H. pylori infection and reflux esophagitis in older patients: case-control study in Japan. Helicobacter . 2000;5(1):24-29. 22. Rouev P, Chakarski I, Doskov D, Dimov G, Staykova E. Laryngopharyngeal symp- toms and gastroesophageal reflux disease. J Voice . 2005;19(3):476-480. 23. Tauber S, Gross M, Issing WJ. Association of laryngopharyngeal symptoms with gastroesophageal reflux disease. Laryngoscope . 2002;112(5):879-886. 24. Ercan I, Cakir BO, Uzel TS, Sakiz D, Karaca C, Turgut S. The role of gastric Heli- cobacter pylori infection in laryngopharyngeal reflux disease. Otolaryngol Head Neck Surg . 2006;135(1):52-55. 25. Postma GN, Johnson LF, Koufman JA. Treatment of laryngopharyngeal reflux. Ear Nose Throat J . 2002;81(9)(suppl 2):24-26. 26. Ching SS, Sabanathan S, Jenkinson LR. Treatment of Helicobacter pylori in sur- gical practice: a randomised trial of triple versus quadruple therapy in a rural dis- trict general hospital. World J Gastroenterol . 2008;14(24):3855-3860.

(REPRINTED) ARCH OTOLARYNGOL HEAD NECK SURG/VOL 136 (NO. 11), NOV 2010 WWW.ARCHOTO.COM

155